Avinger +24% on FDA clearance for Pantheris SV device

|About: Avinger, Inc. (AVGR)|By:, SA News Editor

The FDA grants 510(k) clearance to Avinger's (NASDAQ:AVGR) Pantheris SV (Small Vessel) image-guided atherectomy system.

Pantheris SV is indicated for the diagnosis and treatment of Peripheral Artery Disease in small vessels (2 to 4 millimeters in diameter).

The Company intends to initiate a limited launch in several sites in U.S. when commercial product is available.

Shares are up 24% premarket.

Subscribe for full text news in your inbox